middl
east
respiratori
syndrom
coronaviru
merscov
intern
public
health
challeng
consider
differ
method
report
deathrel
within
countri
case
fatal
rate
account
saudi
arabia
republ
korea
recent
sever
epidemiolog
investig
publish
assess
factor
associ
mortal
mer
patient
howev
find
studi
either
repres
specif
popul
group
intens
care
unit
singl
medic
centr
outbreak
infect
republ
korea
one
studi
analys
publicli
avail
data
saudi
ministri
health
webpag
identifi
factor
associ
mortal
saudi
arabian
patient
one
limit
studi
lack
multivari
risk
model
river
et
al
use
multivari
poisson
regress
model
identifi
factor
associ
high
incid
mortal
studi
exclud
case
republ
korea
recent
studi
chen
et
al
compar
risk
factor
diseas
characterist
south
korean
saudi
arabian
popul
assess
surviv
rate
case
author
previous
publish
studi
merscov
abl
assess
surviv
rate
mer
case
variou
countri
report
world
health
organ
although
mention
studi
provid
valuabl
inform
term
mortal
risk
mer
patient
common
limit
note
previou
studi
global
data
use
associ
differ
geograph
region
mortal
find
report
made
use
data
specif
popul
region
per
author
knowledg
time
larg
crosscountri
comparison
studi
merscovrel
mortal
yet
clear
whether
mortal
rate
merscov
identifi
countri
region
import
understand
compar
merscov
patient
accord
clinic
outcom
multicountri
studi
may
provid
use
multicountri
work
reduc
mortal
merscov
popul
worldwid
current
studi
may
provid
multivari
risk
model
identifi
patient
high
risk
death
order
manag
merscov
patient
clinic
outcom
may
improv
public
health
plan
establish
effect
programm
prevent
seriou
outcom
programm
address
healthcar
system
public
health
polici
goal
studi
estim
compar
variat
riskstandardis
mortal
rate
region
patient
characterist
among
differ
countri
across
world
specif
compar
region
largest
number
merscov
case
author
hypothesis
peopl
older
age
underli
medic
condit
saudi
arabia
middl
east
countri
high
risk
death
relat
merscov
two
primari
end
point
assess
mortal
relat
mer
develop
symptom
studi
author
estim
surviv
rate
use
time
symptom
onset
outcom
merscov
incub
period
day
time
symptom
usual
occur
surviv
rate
mark
medic
signific
demonstr
surviv
point
patient
typic
experi
symptom
mark
select
demonstr
progress
diseas
advanc
period
patient
symptom
author
use
date
laboratori
confirm
instead
date
symptom
onset
patient
surviv
rate
interpret
portion
mer
patient
still
aliv
day
experienc
symptom
statist
analys
perform
sa
version
softwar
data
merscov
patient
report
januari
march
retriev
analys
descript
statist
use
describ
studi
popul
tabl
unadjust
cox
proport
hazard
model
cphm
use
estim
hazard
risk
hr
confid
interv
ci
mortal
tabl
multivari
cphm
use
estim
adjust
hazard
risk
ahr
ci
mortal
adjust
gender
age
region
whether
healthcar
worker
comorbid
asymptomat
sourc
infect
tabl
logrank
test
use
compar
surviv
curv
demograph
diseas
characterist
fig
surviv
rate
estim
use
estim
total
patient
confirm
merscov
infect
includ
analysi
characterist
popul
found
tabl
popul
rel
older
mean
age
year
age
rang
year
merscov
symptom
present
comorbid
healthcareassoci
merscov
infect
greatest
sourc
infect
unknown
sourc
infect
camel
case
report
saudi
arabia
overal
mortal
rate
merscov
patient
includ
studi
mortal
rate
mortal
rate
tabl
illustr
unadjust
adjust
hazard
risk
allcaus
mortal
unadjust
analysi
show
age
group
year
saudi
arabia
middl
east
nonhealthcar
worker
comorbid
symptomat
camelacquir
infect
hospitalacquir
infect
unknown
sourc
infect
associ
higher
elev
mortal
adjust
analysi
show
saudi
arabia
ahr
ci
middl
east
ahr
ci
nonhealthcar
worker
ahr
ci
comorbid
ahr
ci
hospitalacquir
infect
ahr
ci
unknown
sourc
infect
ahr
ci
independ
associ
higher
mortal
tabl
show
unadjust
adjust
hazard
risk
mortal
unadjust
analysi
likelihood
mortal
higher
age
group
year
saudi
arabia
middl
east
nonhealthcar
worker
comorbid
symptomat
camelacquir
infect
hospitalacquir
infect
unknown
sourc
infect
adjust
analysi
show
older
age
year
ahr
ci
saudi
arabia
ahr
ci
nonhealthcar
worker
ahr
ci
comorbid
ahr
ci
symptomat
ahr
ci
camelacquir
infect
ahr
ci
hospitalacquir
infect
ahr
ci
unknown
sourc
infect
ahr
ci
independ
associ
higher
mortal
studi
conduct
estim
surviv
rate
mer
patient
specif
day
experienc
merscov
symptom
determin
whether
signific
differ
surviv
rate
demograph
data
diseas
characterist
region
use
global
mer
data
report
author
use
cphm
estim
calcul
surviv
rate
accord
data
estim
overal
surviv
rate
ci
studi
estim
surviv
rate
ci
ci
respect
author
calcul
regionspecif
surviv
rate
fig
mer
patient
studi
republ
korea
countri
much
higher
surviv
rate
middl
east
saudi
arabia
respect
differ
regionspecif
surviv
rate
remain
signific
account
patient
diseas
factor
gender
age
comorbid
symptom
healthcar
worker
sourc
infect
instanc
hazard
death
postsymptom
time
higher
middl
east
saudi
arabia
compar
republ
korea
countri
respect
dispar
surviv
rate
region
probabl
explain
delay
report
mer
symptom
consequ
delay
diagnosi
median
time
date
onset
symptom
death
lower
republ
korea
countri
middl
east
saudi
arabia
research
studi
requir
assess
whether
diagnost
delay
diseas
characterist
explain
differ
surviv
rate
geograph
region
age
year
older
repres
larg
portion
mer
popul
predominantli
contribut
high
portion
death
well
find
studi
show
surviv
rate
tend
rise
increas
age
fig
similar
women
compar
men
estim
surviv
rate
patient
older
year
patient
age
year
patient
age
year
young
patient
age
year
less
result
support
variou
epidemiolog
cohort
saudi
arabia
republ
korea
state
older
age
risk
factor
death
mer
patient
high
death
rate
among
older
age
group
could
attribut
greater
number
patient
comorbid
group
preval
comorbid
increas
age
young
age
group
year
year
year
older
year
thu
comorbid
may
associ
age
mortal
sever
studi
includ
current
studi
suggest
presenc
underli
condit
associ
increas
hazard
death
mer
patient
detail
underli
condit
need
estim
underli
conditionspecif
surviv
rate
would
use
identifi
underli
condit
associ
lower
surviv
rate
moreov
prevent
diseas
manag
strategi
assess
intervent
mer
patient
underli
condit
reduc
mortal
rate
group
concord
studi
nonhealthcar
worker
associ
lower
surviv
rate
fig
studi
includ
healthcar
worker
five
die
higher
surviv
rate
within
healthcar
worker
group
could
attribut
educ
healthcar
worker
prepared
access
healthcar
follow
proper
infect
control
standard
explan
lower
surviv
rate
nonhealthcar
worker
group
larg
gap
public
awar
clinic
symptom
merscov
public
health
health
system
intervent
need
reduc
spread
mer
rais
public
awar
identifi
clinic
symptom
earli
screen
diagnosi
could
reduc
high
rate
mortal
nonhealthcar
worker
patient
acquir
infect
camel
hospit
unknown
sourc
infect
exhibit
time
higher
mortal
risk
compar
patient
acquir
infect
household
member
respect
fig
healthcar
system
may
use
inform
properli
develop
support
care
plan
improv
patient
outcom
studi
sever
limit
studi
use
avail
data
public
sourc
detail
underli
condit
inform
could
import
identifi
underli
condit
associ
death
patient
condit
clinic
outcom
may
final
data
updat
routin
anoth
potenti
confound
factor
avail
access
healthcar
may
consid
modifi
factor
account
final
inverseprob
curv
may
also
appropri
model
dataset
may
provid
perspect
data
visual
way
show
adjust
surviv
rate
despit
limit
studi
author
abl
use
estim
surviv
rate
measur
time
symptom
onset
outcom
date
studi
provid
surviv
estim
link
region
studi
provid
inform
regionspecif
surviv
rate
found
account
differ
mortal
larg
sampl
size
use
also
main
strength
studi
futur
studi
could
investig
diagnost
delay
defin
differ
date
symptom
onset
time
diagnosi
may
reduc
poor
outcom
studi
estim
surviv
rate
initi
onset
symptom
respect
result
demonstr
link
mortal
geographi
diseas
patient
factor
region
symptom
sourc
infect
underli
medic
condit
mode
transmiss
nonhealthcar
worker
older
age
educ
programm
access
healthcar
earli
diagnosi
could
implement
modifi
factor
reduc
higher
mortal
rate
mer
patient
